Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
about
B cell activation involves nanoscale receptor reorganizations and inside-out signaling by SykThe Homophilic Domain - An Immunological ArchetypeTCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemiaThe role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemiaPI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)New strategies in chronic lymphocytic leukemia: shifting treatment paradigmsTargeting the B-cell receptor signaling pathway in B lymphoid malignanciesThe outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergyBruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomasBruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinibB cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292Idelalisib for the treatment of chronic lymphocytic leukemiaThe pathogenesis of chronic lymphocytic leukemiaSignal transduction in the chronic leukemias: implications for targeted therapiesManagement of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitorsSecondary mutations as mediators of resistance to targeted therapy in leukemiaB-cell receptor signalling and its crosstalk with other pathways in normal and malignant cellsThe European Hematology Association Roadmap for European Hematology Research: a consensus documentThe shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia.Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib.AID-induced remodeling of immunoglobulin genes and B cell fate.Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLLStimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemiaMonoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional studyModeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapyBruton's tyrosine kinase (BTK) inhibitors in clinical trials.BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectThe long elusive IgM Fc receptor, FcμR.B-cell receptor signaling as a driver of lymphoma development and evolution.Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitopeOSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cellsPeptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes.Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton.Antibody repertoire diversification through VH gene replacement in mice cloned from an IgA plasma cell.Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cellsShifting ecologies of malignant and nonmalignant cells following BRAF inhibition.BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.
P2860
Q24299839-AD35A166-1E25-4399-AA0E-6E7D20AE36FFQ26752282-3BB3CEBE-93F3-41C1-84A8-95C8C0940EFCQ26773053-719B6200-8312-4C7B-975A-0F8E1B433091Q26775506-E96EECFD-3279-4F2D-9E8E-0C4262C94500Q26782633-F97459FC-275B-462C-8DB6-F4692BA34F34Q26828496-9329E37F-30EC-4689-9941-114167369F68Q26828782-4352C686-AE45-4F49-9CDE-06EBB6F22F0CQ26865760-0185B5BF-2B08-40F2-9DB8-8734AEBB4F9FQ26991890-79AB0E71-512B-4776-A3F7-93C946E5084FQ26995113-5A7ACC3C-4B28-4CCC-A614-63DAFEE183C0Q27009550-D06AE84B-CFD4-444F-A089-E2BB126E0106Q27015826-EF837F46-9248-4C65-B86F-CF4774477006Q27025715-FC979D1E-7C74-45B3-BABF-A38AF83B8B9BQ27026031-4C546D6C-7166-40BA-A0C5-FF5662BC9D16Q28081162-5496BBA2-A1CD-4B4C-8CB6-57AE94CFAF92Q28087213-3E141C4F-ADBE-4E12-984F-2BB6E2B26C8EQ28245018-9D000564-DA9A-4135-93C0-CC7AB05CAC1DQ28830861-8F6F4A76-8B61-476E-B887-CF7F3FD685D3Q30243968-E7633690-7B31-4520-A569-497276AFF322Q30252869-093E747C-1FF3-4856-9924-78DD9406CB70Q33576896-D0ACA788-5540-4958-B952-912EC5B09D30Q33714712-489099CC-0671-4C46-8ADC-B230633BEBCBQ33749658-828DA53B-6EF2-410B-8141-FFF02389F816Q33804706-913D902C-42CE-4018-A9D8-2FCD68FFDF60Q33860644-D144BD42-17EE-442E-8270-BF9B8953A79DQ34020276-E5A7D77E-349C-4D5A-9E9B-F1C6E2F99962Q34039406-CC796D0A-7DD1-42B9-8818-1216116C87C9Q34041311-87E577FA-D993-4DFA-B91D-4141FEE8947EQ34137880-9B614E79-B0EA-4CE1-8E76-0DEE6836B89EQ34159967-73667F90-C566-4C3C-AD52-E7B57C553093Q34398579-F73D5F15-EF6C-4968-A3A1-C3CED8C8E6E3Q34463658-A47FFC82-E32A-4F23-A33F-83196A9474F5Q34804388-72FE70AF-9627-4299-AB27-33025F5623ABQ34876742-7DC5EB5B-088A-40C5-AE27-017B5D43EA33Q34901206-A3CA6D6A-DD9E-4FA8-B7F8-BF6DF13F736BQ35054626-2C92F1DC-1F9E-451F-BDB1-5F9131785DECQ35062741-2AEF059F-8D6F-4DF9-BAF9-DC12E0E25EC7Q35110849-DC00EB10-1450-48E7-93E7-BD0EBC7F6A20Q35140015-03D1A42B-8A1F-40A5-B645-FD3579D01CBBQ35140116-3FA2459D-9372-40EF-AFD6-DEC6F37CBD8E
P2860
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@ast
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@en
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@nl
type
label
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@ast
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@en
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@nl
prefLabel
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@ast
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@en
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@nl
P2093
P2860
P3181
P356
P1433
P1476
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
@en
P2093
Daniel Hofmann
Dunja Schneider
Elena Surova
Fabian Köhler
Hassan Jumaa
Hedda Wardemann
Katja Zirlik
Maike Buchner
Marcus Dühren-von Minden
Martina P Bach
P2860
P2888
P304
P3181
P356
10.1038/NATURE11309
P407
P577
2012-09-13T00:00:00Z
P5875
P6179
1000301913